Skip to main content

About Moberg Open link menu
About Moberg

CEO Comments

Business Model

Board and Leadership
MOB-015
Sustainability
Investors Open link menu
Investors

Results and Presentations

The share Open link menu

The share

Major shareholders

Insider Trading

Financial Data

Analysts

Calender

Corporate governance Open link menu

Corporate governance

Board of directors

Management

General shareholders meetings

Nomination committee

Auditors

Remuneration

Share-based incentive program

Articles of Association

Press releases

Prospectus
Media Open link menu
Media

Image Archive

Press Releases
Contact

- Current language English, click to switch language
- Switch to Swedish
Search on a site

Please fill out this field

Close

Search on a site

Please fill out this field

Analysts

Breadcrumbs

Home
Investors
Analysts

Analysts

Equity analysts who continuously monitor Moberg Pharma:

Jessica Grunewald, Redeye
E-mail: [email protected]
Latest report available here

Analysts - Equity analysts

Moberg Pharma AB
Telephone: 08-522 307 00
Email: [email protected]

Mailing Address:
Gustavslundsvägen 42, 167 51 Bromma
Visiting Address:
Gustavslundsvägen 50, 167 51 Bromma

Sign up to receive our press releases and reports.

Moberg Pharma´s Interim report January - September 2024

Footer

Sitemap
Privacy Policy
Terms of Use
Cookies
Copyright
Cookie settings
© Moberg Pharma AB (publ) 2025